AR089990A1 - Dispositivo con nucleo y recubrimiento para la liberacion de farmacos - Google Patents

Dispositivo con nucleo y recubrimiento para la liberacion de farmacos

Info

Publication number
AR089990A1
AR089990A1 ARP130100457A ARP130100457A AR089990A1 AR 089990 A1 AR089990 A1 AR 089990A1 AR P130100457 A ARP130100457 A AR P130100457A AR P130100457 A ARP130100457 A AR P130100457A AR 089990 A1 AR089990 A1 AR 089990A1
Authority
AR
Argentina
Prior art keywords
coating
core
pharmacos
nucleus
release
Prior art date
Application number
ARP130100457A
Other languages
English (en)
Inventor
Loxley Andrew
Mitchnick Mark
Hernandez Herrero Gonzalo
Ronchi Celestino
Original Assignee
Chemo Res S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Res S L filed Critical Chemo Res S L
Publication of AR089990A1 publication Critical patent/AR089990A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
    • A61F6/142—Wirelike structures, e.g. loops, rings, spirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Nanotechnology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Dispositivo que comprende (a) un núcleo que comprende poliuretano; (b) un recubrimiento que comprende copolímero de etileno vinil acetato, rodeando dicho recubrimiento sustancialmente o completamente a dicho núcleo; y (c) uno o más ingredientes farmacéuticos activos disueltos o dispersados en dicho núcleo y/o dicho recubrimiento: y a un procedimiento para su preparación. Reivindicación 5: El dispositivo según cualquiera de las reivindicaciones 1 - 4, que comprende un estrógeno. Reivindicación 8: El dispositivo según cualquiera de las reivindicaciones 1 - 4 que comprende una progestina. Reivindicación 19: El dispositivo según cualquiera de las reivindicaciones 1 - 18, donde el dispositivo es un anillo vaginal.
ARP130100457A 2012-02-14 2013-02-14 Dispositivo con nucleo y recubrimiento para la liberacion de farmacos AR089990A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261598642P 2012-02-14 2012-02-14

Publications (1)

Publication Number Publication Date
AR089990A1 true AR089990A1 (es) 2014-10-01

Family

ID=47749791

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130100457A AR089990A1 (es) 2012-02-14 2013-02-14 Dispositivo con nucleo y recubrimiento para la liberacion de farmacos

Country Status (17)

Country Link
US (2) US9132081B2 (es)
EP (3) EP2814458B1 (es)
AR (1) AR089990A1 (es)
CY (1) CY1121563T1 (es)
DK (1) DK2814458T3 (es)
ES (1) ES2730208T3 (es)
HR (1) HRP20190716T1 (es)
HU (1) HUE043105T2 (es)
LT (1) LT2814458T (es)
PL (1) PL2814458T3 (es)
PT (1) PT2814458T (es)
RS (1) RS58690B1 (es)
SI (1) SI2814458T1 (es)
TR (1) TR201906738T4 (es)
TW (1) TW201332585A (es)
UY (1) UY34625A (es)
WO (1) WO2013120888A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3052084A1 (en) * 2013-09-30 2016-08-10 Universiteit Gent Polyurethanes as oral drug delivery platform
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
WO2015086489A1 (en) 2013-12-11 2015-06-18 Merck Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
JP7407595B2 (ja) * 2016-10-05 2024-01-04 タイタン ファーマシューティカルズ インコーポレイテッド バースト放出を低減する薬剤送達用の埋込可能な装置
EP3395335A1 (en) * 2017-04-24 2018-10-31 Kern Pharma, S.L. Vaginal ring for the simultaneous release of two active ingredients
CN109248139A (zh) * 2017-07-14 2019-01-22 国家卫生计生委科学技术研究所 复方左炔诺孕酮阴道环的制备方法和应用
EP3801462A4 (en) 2018-05-24 2022-03-16 Celanese EVA Performance Polymers LLC IMPLANTABLE DEVICE FOR EXTENDED RELEASE OF A MACROMOLECULAR DRUG COMPOUND
KR20210013089A (ko) 2018-05-24 2021-02-03 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치
EP4215181A1 (en) 2022-01-21 2023-07-26 Sever Pharma Solutions An intravaginal ring
EP4215180A1 (en) 2022-01-21 2023-07-26 Sever Pharma Solutions A drug delivery system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
ES2327247T3 (es) * 2004-03-24 2009-10-27 N.V. Organon Sistema de administracion de farmacos basado en copolimeros de polietileno y acetato de vinilo.
MX2009005364A (es) * 2006-11-20 2009-06-05 Organon Nv Sistema de suministro de farmaco con forma helicoidal.
WO2008089488A2 (en) * 2007-01-19 2008-07-24 University Of Utah Research Foundation Biodegradable intravaginal devices for delivery of therapeutics
WO2008100876A1 (en) 2007-02-12 2008-08-21 Particle Sciences, Inc. Delivery devices containing encapsulated and/or particle-bound active pharmaceutical ingredients
EP2244782A4 (en) 2008-01-25 2011-09-14 Univ Utah Res Found POLYMER FOR LINEAR RELEASE
US20100040671A1 (en) 2008-08-12 2010-02-18 Ahmed Salah U Intravaginal Devices With a Rigid Support, Methods of Making, and Uses Thereof
AU2011227289B2 (en) 2010-03-16 2016-01-21 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery

Also Published As

Publication number Publication date
US9872829B2 (en) 2018-01-23
EP3449909A2 (en) 2019-03-06
RS58690B1 (sr) 2019-06-28
PT2814458T (pt) 2019-05-30
PL2814458T3 (pl) 2019-08-30
EP4212146A2 (en) 2023-07-19
US9132081B2 (en) 2015-09-15
US20130209539A1 (en) 2013-08-15
WO2013120888A3 (en) 2013-10-31
EP3449909A3 (en) 2019-05-29
TR201906738T4 (tr) 2019-05-21
HUE043105T2 (hu) 2019-08-28
WO2013120888A2 (en) 2013-08-22
EP4212146A3 (en) 2023-09-27
EP2814458A2 (en) 2014-12-24
CY1121563T1 (el) 2020-05-29
US20160000706A1 (en) 2016-01-07
UY34625A (es) 2013-09-02
SI2814458T1 (sl) 2019-06-28
TW201332585A (zh) 2013-08-16
EP2814458B1 (en) 2019-04-10
HRP20190716T1 (hr) 2019-06-14
DK2814458T3 (da) 2019-05-13
LT2814458T (lt) 2019-05-27
ES2730208T3 (es) 2019-11-08

Similar Documents

Publication Publication Date Title
AR089990A1 (es) Dispositivo con nucleo y recubrimiento para la liberacion de farmacos
DOP2015000202A (es) Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno
PH12019501360A1 (en) Glp-1 receptor agonists and uses thereof
CL2017001930A1 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-ona
IN2015DN03167A (es)
UY35639A (es) Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CL2013000718A1 (es) Un complejo de inclusion que comprende a) una ciclodextrina, b) fulvestrant y c) un portador; su metodo de preparacion; formulacion y forma de dosificacion que comprende al complejo; preparacion que comprende al complejo o a la formulación; y su uso en el tratamiento del cancer y lupus eritematoso sistemico, entre otras enfermedades.
CL2015002222A1 (es) Compuestos de azabencimidazol como inhibidores de isoenzimas pde4 para el tratamiento del snc y otros trastornos.
AR093645A1 (es) Una formulacion estabilizada de pemetrexed
CL2013002650A1 (es) Compuestos derivados triciclicos con actividad sobre los receptores hormonales nucleares; composicion farmaceutica que los comprende; proceso de reparacion de compuestos intermediarios; y uso en el tratamiento del sida, insuficiencia adrenal aguda, enfermedad de addison, rinitis alergica, enfermedad de alzheimer, entre otros.
BR112016021023A8 (pt) composições de corticosteroides tópicos
DOP2017000073A (es) Nuevos activadores de la guanilato ciclasa soluble y su uso
IN2013MU00711A (es)
TWD189982S (zh) 注射裝置的容器
PH12014502834B1 (en) Pharmaceutical form for extended release of active substances
GT201300304A (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
CL2016000944A1 (es) Nueva formulación de ganadotropinas
PE20151300A1 (es) Composicion antifungica topica para el tratamiento de onicomicosis
CL2016001130A1 (es) Composiciones sólidas de triglicéridos y usos de estas
CL2016001024A1 (es) Compuestos derivados de pirido[4,3-b]pirazin-2-carboxamidas; procedimiento de preparacion; composicion farmaceutica y uso para el tratamiento de trastornos neurodegenerativos, esquizofrenia, depresion, entre otras enfermedades.
UY34273A (es) Derivados de furo[3,4-c]quinolina, medicamentos que contienen dichos compuestos, su uso y proceso para su preparación
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
BR112015030129A2 (pt) ésteres sulfatados de ácido oligohidróxi carboxílico e seu uso
BR112015030135A2 (pt) ésteres de ácidos oligo-hidróxi carboxílicos e seu uso

Legal Events

Date Code Title Description
FB Suspension of granting procedure